跳至主要内容
临床试验/EUCTR2010-019252-41-AT
EUCTR2010-019252-41-AT进行中(未招募)不适用

DALI dosing study of Vitamin D in obese pregnant women - DALI

VU University Medical Center0 个研究点目标入组 60 人开始时间: 2011年7月19日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • pre-pregnancy BMI (self-reported weight, measured height) is = 29 kg/m2)
  • aged 18 years or more
  • singleton pregnancy
  • gestational age at recruitment < 12 weeks
  • sufficiently fluent in major language of the country of recruitment
  • being able to be moderately physically active
  • giving written informed consent
  • agreeing to give birth in one of the participating hospitals
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • pre-existing diabetes
  • diagnosed with (gestational) diabetes mellitus before randomisation
  • not able to walk at least 100 meters safely
  • requirement for complex diets
  • advanced chronic conditions (e.g. valvular heart disease)
  • significant psychiatric disease
  • unable to speak major language of the country of recruitment fluently
  • known current or past abnormal calcium metabolism (hypo/hyperparathyroidism, nephrolithiasis, hypercalciuria)
  • hypercalciuria detected at screening (>0.6 mmol/mmol creatinine in spot morning urine) hypercalcaemia detected at screening (>10.6 mg/dl |2.65 mmol/l)

研究者

发起方
VU University Medical Center

相似试验

DALI: finding the right dose of Vitamin D for obese... | 临床试验